8-K: Vivakor Secures $1.05 Million in Funding Through Share Purchase Agreements

Vivakor, Inc. has entered into agreements to sell a total of 1,735,135 common shares for $1.05 million to James K. Granger and ClearThink Capital Partners, LLC.

Summary

• Vivakor, Inc. has entered into a Securities Purchase Agreement with James K. Granger to sell 1,600,000 common shares at $0.50 per share, totaling $800,000.
• The shares will be delivered via book entry within seven calendar days following the closing date, which is on or about July 31, 2024.
• Granger has represented that the shares are for investment purposes and not for distribution.
• Vivakor also entered into a separate Securities Purchase Agreement with ClearThink Capital Partners, LLC to sell 135,135 restricted common shares at $1.85 per share, totaling $250,000.
• The sale to ClearThink is split into two closings, with the first on or about July 31, 2024, and the second within five days after the filing of the S-1 Registration Statement underlying the Purchase Agreement.
• ClearThink has also represented that these shares are for investment purposes and not for distribution.

Sentiment

Score: 7

Explanation: The document indicates a positive development for the company as it secures funding, but the restrictions on the shares and reliance on exemptions temper the overall sentiment.

Positives

• Vivakor secures $1.05 million in funding through the sale of common shares.
• The agreements provide immediate capital to the company.
• The investment representations from both purchasers suggest a long-term commitment to the company.

Negatives

• The shares issued to both Granger and ClearThink are restricted, meaning they cannot be immediately resold on the open market.
• The company is relying on exemptions from securities registration, which may limit the flexibility of future transactions.

Risks

• The shares issued are subject to Rule 144 restrictions, which limits their immediate resale.
• The company's reliance on exemptions from registration may pose challenges in future capital raising activities.
• The second closing with ClearThink is contingent on the filing of an S-1 Registration Statement, which could introduce delays.

Future Outlook

The company anticipates completing the share sales and receiving the funds, with the second closing of the ClearThink transaction dependent on the filing of an S-1 Registration Statement.

Industry Context

This type of private placement is a common method for small to mid-sized companies to raise capital, especially when they are seeking to avoid the complexities of a public offering.

Comparison to Industry Standards

• The pricing of the shares in the Granger transaction at $0.50 per share is below the price in the ClearThink transaction at $1.85 per share, which may reflect different risk profiles or the timing of the investments.
• The use of Rule 144 restricted stock is standard practice in private placements, limiting the immediate liquidity of the shares for the investors.
• The agreements include standard clauses regarding investment representations, governing law, and indemnification, which are typical in these types of transactions.

Stakeholder Impact

• Shareholders will see an increase in the number of outstanding shares, which could potentially dilute their ownership.
• The company will have additional capital to fund operations and growth.
• The transactions may increase investor confidence in the company's ability to raise capital.

Next Steps

• The company will complete the share issuance to James K. Granger.
• The company will complete the first closing of the share issuance to ClearThink Capital Partners, LLC.
• The company will file the S-1 Registration Statement to enable the second closing with ClearThink Capital Partners, LLC.

Key Dates

Keywords

securities purchase agreement, common shares, restricted stock, capital raise, private placement, Rule 144, accredited investor, Vivakor, ClearThink Capital Partners, James K. Granger